Developments in the clinical understanding of lupus

por Crow, Mary K
Publicado 2009

Type I interferon in organ-targeted autoimmune and inflammatory diseases

por Crow, Mary K
Publicado 2010

Microarray analysis of gene expression in lupus

por Crow, Mary K, Wohlgemuth, Jay
Publicado 2003

Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases

por Crow, Mary K, Rönnblom, Lars
Publicado 2018

Type I interferons in host defence and inflammatory diseases

por Crow, Mary K., Ronnblom, Lars
Publicado 2019

Interferon-induced versus chemokine transcripts as lupus biomarkers

por Crow, Mary K, Kirou, Kyriakos A
Publicado 2008

When a Diagnosis Has No Name: Uncertainty and Opportunity

por Lockshin, Michael D., Crow, Mary K., Barbhaiya, Medha
Publicado 2021

Investigation of Possible Link between Interferon-α and Lyme Disease

por Alaedini, Armin, Crow, Mary K., Fallon, Brian A., Jacek, Elzbieta, Wormser, Gary P.
Publicado 2023

SLE: reconciling heterogeneity

por Lockshin, Michael D, Barbhaiya, Medha, Izmirly, Peter, Buyon, Jill P, Crow, Mary K
Publicado 2019

A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

por Pothlichet, Julien, Niewold, Timothy B, Vitour, Damien, Solhonne, Brigitte, Crow, Mary K, Si-Tahar, Mustapha
Publicado 2011

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations

por Mavragani, Clio P., Niewold, Timothy B., Chatzigeorgiou, Antonis, Danielides, Stamatina, Thomas, Dimitrios, Kirou, Kyriakos A., Kamper, Elli, Kaltsas, Grigorios, Crow, Mary K.
Publicado 2013

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

por Gordon, Jessica K., Martyanov, Viktor, Magro, Cynthia, Wildman, Horatio F., Wood, Tammara A., Huang, Wei-Ti, Crow, Mary K., Whitfield, Michael L., Spiera, Robert F.
Publicado 2015

Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus

por Kariuki, Silvia N, Franek, Beverly S, Kumar, Akaash A, Arrington, Jasmine, Mikolaitis, Rachel A, Utset, Tammy O, Jolly, Meenakshi, Crow, Mary K, Skol, Andrew D, Niewold, Timothy B
Publicado 2010

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

por Spiera, Robert F, Gordon, Jessica K, Mersten, Jamie N, Magro, Cynthia M, Mehta, Mansi, Wildman, Horatio F, Kloiber, Stacey, Kirou, Kyriakos A, Lyman, Stephen, Crow, Mary K
Publicado 2011

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome

por Fragkioudaki, Sofia, Nezos, Adrianos, Souliotis, Vassilis L., Chatziandreou, Ilenia, Saetta, Angelica A., Drakoulis, Nikolaos, Tzioufas, Athanasios G., Voulgarelis, Michael, Sfikakis, Petros P., Koutsilieris, Michael, Crow, Mary K., Moutsopoulos, Haralampos M., Mavragani, Clio P.
Publicado 2017

Interferon-alpha and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia

por Andrade, Danieli, Kim, Mimi, Blanco, Luz P, Karumanchi, S Ananth, Koo, Gloria C, Redecha, Patricia, Kirou, Kyriakos, Alvarez, Angela M, Mulla, Melissa J, Crow, Mary K, Abrahams, Vikki M, Kaplan, Mariana J, Salmon, Jane E
Publicado 2014

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

por Chaudhary, Vidyanath, Ah Kioon, Marie Dominique, Hwang, Sung-Min, Mishra, Bikash, Lakin, Kimberly, Kirou, Kyriakos A., Zhang-Sun, Jeffrey, Wiseman, R. Luke, Spiera, Robert F., Crow, Mary K., Gordon, Jessica K., Cubillos-Ruiz, Juan R., Barrat, Franck J.
Publicado 2022

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to c...

por Rodríguez-Carrio, Javier, Burska, Agata, Conaghan, P G, Dik, Willem A, Biesen, Robert, Eloranta, Maija-Leena, Cavalli, Giulio, Visser, Marianne, Boumpas, Dimitrios T, Bertsias, George, Wahren-Herlenius, Marie, Rehwinkel, Jan, Frémond, Marie-Louise, Crow, Mary K, Ronnblom, Lars, Vital, Ed, Versnel, Marjan
Publicado 2023

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

por Burska, Agata, Rodríguez-Carrio, Javier, Biesen, Robert, Dik, Willem A, Eloranta, Maija-Leena, Cavalli, Giulio, Visser, Marianne, Boumpas, Dimitrios T, Bertsias, George, Wahren-Herlenius, Marie, Rehwinkel, Jan, Frémond, Marie-Louise, Crow, Mary K, Ronnblom, Lars, Conaghan, PG, Versnel, Marjan, Vital, Ed
Publicado 2023

Identification of a central role for complement in osteoarthritis

por Wang, Qian, Rozelle, Andrew L., Lepus, Christin M., Scanzello, Carla R., Song, Jason J., Larsen, D. Meegan, Crish, James F., Bebek, Gurkan, Ritter, Susan Y., Lindstrom, Tamsin M., Hwang, Inyong, Wong, Heidi H., Punzi, Leonardo, Encarnacion, Angelo, Shamloo, Mehrdad, Goodman, Stuart B., Wyss-Coray, Tony, Goldring, Steven R., Banda, Nirmal K., Thurman, Joshua M., Gobezie, Reuben, Crow, Mary K., Holers, V. Michael, Lee, David M., Robinson, William H.
Publicado 2011